Allstate Corporation’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Allstate Corporation's TGTX Position: Q3 2026 in Review
Allstate Corporation increased its TG Therapeutics (TGTX) stake by 0.32% in Q3 2026, buying an estimated $1.73K and bringing the position to 9,911 shares worth $553K. The position accounts for 0.01% of the portfolio, ranked #797.
Allstate Corporation first reported a position in TGTX in Q4 2020 and has held it in 5 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Allstate Corporation held 9,911 shares of TG Therapeutics worth $553K as of Q3 2026.
- Allstate Corporation bought 32 TG Therapeutics shares in Q3 2026, an estimated $1.73K.
- TG Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #797 holding.
- Allstate Corporation first reported a position in TG Therapeutics in Q4 2020 and has held it in 5 quarters since.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.